您的当前位置:首页 > 行业数据 > 索凡替尼临床管线进展(截至2024年7月)
图片属性
图片格式:PNG 图片大小:251KB 图片尺寸:1830*446
同报告图片
 / 4
索凡替尼临床管线进展(截至2024年7月)_第1页
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
索凡替尼临床管线进展(截至2024年7月)_第2页
fCDlubTku70gfCDluILlnLrplIDllK7pop3vvIjnmb7kuIfnvo7lhYPvvIkgfCDlop7plb/njocgfCBDRVLlop7plb/njocgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS18LS0tLS0tLS0tLS0tfAp8IDIwMjIgfCA5My41ICAgICAgICAgICAgICAgICB8ICAgICAgICB8ICAgICAgICAgICAgfAp8IDIwMjMgfCAxMDcuNSAgICAgICAgICAgICAgICB8ICsxNSUgICB8ICsyMiUgICAgICAgfAp8IDIwMjQgfCAxMTUuMCAgICAgICAgICAgICAgICB8ICs3JSAgICB8ICs5JSAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5YWs5Y+45ryU56S65p2Q5paZ77yM5Lit5rOw6K+B5Yi456CU56m25omA
索凡替尼临床管线进展(截至2024年7月)_第3页
索凡替尼临床管线进展(截至2024年7月)_第4页
索凡替尼临床管线进展(截至2024年7月)_第5页
所属报告: 和黄医药-港股公司深度报告:小分子药物研发领军者创新驱动全球化-250401(25页).pdf
打包全文图表

相关数据

客服
商务合作
小程序
服务号
折叠